| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Doxorubicin | 23214-92-8 | sc-280681 sc-280681A | 1 mg 5 mg | $173.00 $418.00 | 43 | |
Doxorubicin, by intercalating into DNA, could obstruct the transcription machinery from accessing the OR5B21 gene, thereby downregulating its expression. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
By inhibiting histone deacetylases, Trichostatin A would cause hyperacetylation of histones, potentially leading to the chromatin remodeling that results in the decreased expression of the OR5B21 gene. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-Azacytidine might incorporate into the OR5B21 gene locus, leading to hypomethylation and transcriptional silencing, hence reducing the expression of the OR5B21 protein. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $73.00 $238.00 $717.00 $2522.00 $21420.00 | 53 | |
This compound binds to the DNA at the transcription initiation complex, potentially halting the transcription of OR5B21 mRNA, which would result in lower levels of OR5B21 protein. | ||||||
Pladienolide B | 445493-23-2 | sc-391691 sc-391691B sc-391691A sc-391691C sc-391691D sc-391691E | 0.5 mg 10 mg 20 mg 50 mg 100 mg 5 mg | $290.00 $5572.00 $10815.00 $25000.00 $65000.00 $2781.00 | 63 | |
The binding of Pladienolide B to the spliceosome could lead to defective mRNA splicing of the OR5B21 pre-mRNA, possibly resulting in nonsense-mediated decay and decreased levels of functional OR5B21 protein. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
Rapamycin inhibits the mTOR pathway, which is crucial for mRNA translation. Inhibition of this pathway could lead to a reduction in the synthesis of the OR5B21 protein. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $132.00 $1064.00 | 115 | |
Bortezomib inhibits the 26S proteasome, potentially causing an accumulation of ubiquitinated OR5B21 proteins, which may lead to enhanced degradation and a consequent decrease in the level of OR5B21 protein. | ||||||
17-AAG | 75747-14-7 | sc-200641 sc-200641A | 1 mg 5 mg | $66.00 $153.00 | 16 | |
17-AAG disrupts the function of heat shock protein 90 (HSP90), which may lead to the destabilization and degradation of client proteins, including potentially OR5B21, resulting in its reduced expression. | ||||||
Thalidomide | 50-35-1 | sc-201445 sc-201445A | 100 mg 500 mg | $109.00 $350.00 | 8 | |
Thalidomide could downregulate the expression of OR5B21 by inhibiting the synthesis of transcription factors or the signaling pathways that control the transcription of the OR5B21 gene. | ||||||
Neomycin sulfate | 1405-10-3 | sc-3573 sc-3573A | 1 g 5 g | $26.00 $34.00 | 20 | |
Neomycin, by binding to ribosomal RNA, could inhibit the translation of mRNA, potentially leading to reduced synthesis of the OR5B21 protein due to decreased translation efficiency. | ||||||